Glycostem-Therapeutics B.v.

Where the EU money came from

Funding by EU programme. Amounts are Glycostem-Therapeutics B.v.'s own share of each project, not the project's full budget.

Projects

2 EU-funded projects, newest first. Each links to the official record.

• MATURE-NKPartner

  MAnufacturing of TUmour-REactive Natural Killer cells

  Horizon 2020 · 2018–2022 · Project on CORDIS ↗

  €255ktheir share
• NATURIMMUNPartner

  Natural Killer Cell-Based Anti-Cancer Immunotherapies:Research training in molecular medicine and biotechnology business

  FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗

  €237ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• The Hebrew University of JerusalemIsrael · 2 shared projects
• Institut PasteurFrance · 2 shared projects
• Universidad Pompeu FabraSpain · 2 shared projects
• Medizinische Universitaet WienAustria · 2 shared projects
• Medizinische Hochschule HannoverGermany · 2 shared projects
• Miltenyi Biotec GmbHGermany · 2 shared projects
• Fraunhofer Gesellschaft zur Forderung der Angewandten Forschung eVGermany · 1 shared project
• The Chancellor Masters and Scholars of the University of CambridgeUnited Kingdom · 1 shared project
• King'S College LondonUnited Kingdom · 1 shared project
• University College LondonUnited Kingdom · 1 shared project
• Ruprecht-Karls-Universitaet HeidelbergGermany · 1 shared project
• Universitat BaselSwitzerland · 1 shared project
• Oslo Universitetssykehus HfNorway · 1 shared project
• Miltenyi Biotec BV & Co KGGermany · 1 shared project
• Irccs Azienda Ospedaliera MetropolitanaItaly · 1 shared project
• Innate PharmaFrance · 1 shared project

Fields it works in

Research fields recorded on its Horizon projects.

• business and management
• cells technologies
• genetic engineering
• immunotherapy
• inflammatory diseases
• oncology
• personalized medicine
• pharmaceutical drugs
• stem cells